form8k-2010annual.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): April 30, 2010
Arrhythmia
Research Technology, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of Incorporation or organization)
|
1-9731
(Commission
File Number)
|
72-0925679
(I.R.S.
Employer Identification Number)
|
25 Sawyer
Passway
Fitchburg,
MA 01420
(Address
of principal executive offices and zip code)
(978)
345-5000
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.07. Submission of Matters to
a Vote of Security Holders.
On April
30, 2010, the Company held its Annual Meeting of Stockholders. The following is
a tabulation of the voting on the proposals presented at the Annual
Meeting.
Proposal
1: The election of Dr. Paul F. Walter as a Class III director, to serve for
three years and until his successor has been duly elected and
qualified.
|
Shares Voted For
|
Shares Withheld
|
Broker Non-Votes
|
Dr.
Paul F. Walter
|
1,362,915
|
59,461
|
787,217
|
The terms
of office of Mr. James E. Rouse and Mr. Jason R. Chambers (Class I directors)
and E.P. Marinos and Julius Tabin (Class II directors) continued after the
Annual Meeting.
Proposal
2: The approval of the adoption of the Company’s 2010 Equity
Incentive Plan.
Shares Voted For
|
Shares Voted Against
|
Shares Abstaining
|
Broker Non-Votes
|
1,008,023
|
406,604
|
7,749
|
787,217
|
Proposal
3: The ratification of the appointment of CCR, LLP as the Company’s
independent registered public accounting firm for the year ending December 31,
2010.
Shares Voted For
|
Shares Voted Against
|
Shares Abstaining
|
Broker Non-Votes
|
2,204,077
|
2,096
|
3,420
|
-
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Fitchburg, Commonwealth of Massachusetts, on the
5th day
of May, 2010.
|
ARRHYTHMIA
RESEARCH TECHNOLOGY, INC.
|
|
By: /s/ David A.
Garrison
|
|
Executive
Vice President and
|